Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan R Cook

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Substance Abuse|October 16, 2023
Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use DisorderRyan R Cook, Erin N Jaworski, Kim A Hoffman, et al.
Cancer|February 9, 2017
Treatment trends for patients with brain metastases: Does practice reflect the data?Kiri A Sandler, Narek Shaverdian, Ryan R Cook, et al.
Journal of General Internal Medicine|February 25, 2025
Opioid Treatment Programs and Risks for COVID-19 Infections, Emergency Visits, and HospitalizationsRyan R Cook, Kendra L Blalock, Sanae El Ibrahimi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 14, 2018
Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation OncologyKiri A Sandler, Sandra A Mitchell, Ethan Basch, et al.
Drug and Alcohol Dependence|May 23, 2022
Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexoneJudith I Tsui, Aimee N C Campbell, Martina Pavlicova, et al.
Drug and Alcohol Dependence|September 26, 2025
Preferences for clinical trial participation among people who use drugs in rural Oregon and Appalachian OhioKathryn E Lancaster, Caroline W Koudelka, Miriam R Elman, et al.
Open Forum Infectious Diseases|April 8, 2020
Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure ProphylaxisJennifer A Fulcher, Fan Li, Ryan R Cook, et al.
AIDS (London, England)|January 17, 2019
Effects of HIV viremia on the gastrointestinal microbiome of young MSMRyan R Cook, Jennifer A Fulcher, Nicole H Tobin, et al.
Addiction Science & Clinical Practice|August 19, 2022
Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort studyDaniel M Hartung, Sheila Markwardt, Kirbee Johnston, et al.
Addiction (Abingdon, England)|November 25, 2025
Can a participant-referred 'study buddy' increase retention of rural people who use drugs in research? A multi-site, randomized trialApril M Young, Kathryn E Lancaster, Miriam R Elman, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Substance Abuse|October 16, 2023
Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use DisorderRyan R Cook, Erin N Jaworski, Kim A Hoffman, et al.
Cancer|February 9, 2017
Treatment trends for patients with brain metastases: Does practice reflect the data?Kiri A Sandler, Narek Shaverdian, Ryan R Cook, et al.
Journal of General Internal Medicine|February 25, 2025
Opioid Treatment Programs and Risks for COVID-19 Infections, Emergency Visits, and HospitalizationsRyan R Cook, Kendra L Blalock, Sanae El Ibrahimi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 14, 2018
Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation OncologyKiri A Sandler, Sandra A Mitchell, Ethan Basch, et al.
Drug and Alcohol Dependence|May 23, 2022
Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexoneJudith I Tsui, Aimee N C Campbell, Martina Pavlicova, et al.
Drug and Alcohol Dependence|September 26, 2025
Preferences for clinical trial participation among people who use drugs in rural Oregon and Appalachian OhioKathryn E Lancaster, Caroline W Koudelka, Miriam R Elman, et al.
Open Forum Infectious Diseases|April 8, 2020
Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure ProphylaxisJennifer A Fulcher, Fan Li, Ryan R Cook, et al.
AIDS (London, England)|January 17, 2019
Effects of HIV viremia on the gastrointestinal microbiome of young MSMRyan R Cook, Jennifer A Fulcher, Nicole H Tobin, et al.
Addiction Science & Clinical Practice|August 19, 2022
Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort studyDaniel M Hartung, Sheila Markwardt, Kirbee Johnston, et al.
Addiction (Abingdon, England)|November 25, 2025
Can a participant-referred 'study buddy' increase retention of rural people who use drugs in research? A multi-site, randomized trialApril M Young, Kathryn E Lancaster, Miriam R Elman, et al.
Pageof 4